Guide price only. Final cost is confirmed after assessment.
Monovisc Injection represents a significant advancement in treating osteoarthritis knee pain. This innovative, single-shot hyaluronic acid treatment at London Cartilage Clinic offers patients a simple yet effective solution for managing knee pain associated with osteoarthritis. With its unique formulation and proven effectiveness, Monovisc Injection stands out as a preferred choice for those seeking relief from joint discomfort.
Reviewed byProfessor Paul Lee MBBch, FRCS (Tr & Orth), PhDCartilage and joint preservation expertise
Monovisc is a highly purified hyaluronic acid viscosupplement designed to mimic the knee’s natural lubrication and cushioning properties.
It is commonly considered for patients who have persistent symptoms despite first-line conservative management.
Monovisc offers a convenient, single-injection pathway for knee osteoarthritis symptom control with minimal disruption to routine life.
At London Cartilage Clinic, ultrasound-guided technique and specialist follow-up are used to optimise treatment precision and track your functional response.
The onset of pain relief with Monovisc Injection varies, but many patients report a noticeable improvement in knee pain within a few weeks after the injection.
Monovisc Injection is ideal for patients with knee osteoarthritis who haven’t found relief with traditional treatments. However, it’s important to consult with our specialists to determine if it’s the right option for you.
Monovisc Injection is generally well-tolerated, but like any medical treatment, it may have side effects. Our clinic ensures a thorough assessment to minimize any risks.
A trained specialist uses a single injection to administer Monovisc. This is known as viscosupplementation. During the procedure, the patient will either be lying down or sitting, and a local anaesthetic may be used. The injected area is cleaned and bandaged after the Monovisc has been administered.
The Monovisc injection contains ultra-pure hyaluronic acid, which can be found in the synovial fluid of the knee joint. This gel-like substance lubricates the joint, helping prevent damage and discomfort that might lead to pain. By allowing the bones of the joint to move more freely, Monovisc injections also help delay the onset of osteoarthritis.
Most patients will be able to go for a repeat procedure after six months. However, this may not be true depending on your situation. If your osteoarthritis is deemed to be too advanced, then your surgeon may advise knee replacement surgery.
Still have more specific concerns?
Free Discovery CallLondon Cartilage Clinic
Clinical updates, cartilage treatment guidance, and recovery-focused articles from our specialist team.
Cartilage defects larger than roughly 10 cm² exceed the capability of autograft and cell-based repair; fresh osteochondral allograft — composite tissue of donor cartilage and bone — becomes the reconstructive option. Viable chondrocytes persist only 28 days post-procurement, restricting the procedure to centres with tissue-bank access.
ChondroFiller®, marketed as German cartilage gel, is a Class III medical device made from non-living mouse collagen that recruits the patient's own cells to rebuild cartilage tissue as the scaffold biodegrades.
An MRI partial ACL tear shows some fibres intact and others failed, but this anatomy does not predict whether the knee will be stable or need surgery. The same residual structure permits normal cycling in one patient yet produces giving-way episodes in an athlete who pivots at speed.
